Annual Operating Profit
-$7.43 M
+$355.20 K+4.56%
December 31, 2023
Summary
- As of February 7, 2025, EVOK annual operating income is -$7.43 million, with the most recent change of +$355.20 thousand (+4.56%) on December 31, 2023.
- During the last 3 years, EVOK annual operating profit has risen by +$5.62 million (+43.05%).
- EVOK annual operating profit is now -271.10% below its all-time high of -$2.00 million, reached on December 31, 2012.
Performance
EVOK Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$1.29 M
-$62.10 K-5.08%
September 30, 2024
Summary
- As of February 7, 2025, EVOK quarterly operating income is -$1.29 million, with the most recent change of -$62.10 thousand (-5.08%) on September 30, 2024.
- Over the past year, EVOK quarterly operating profit has increased by +$602.20 thousand (+31.90%).
- EVOK quarterly operating profit is now -532.10% below its all-time high of -$203.40 thousand, reached on June 30, 2013.
Performance
EVOK Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$5.90 M
+$317.70 K+5.11%
September 30, 2024
Summary
- As of February 7, 2025, EVOK TTM operating income is -$5.90 million, with the most recent change of +$317.70 thousand (+5.11%) on September 30, 2024.
- Over the past year, EVOK TTM operating profit has increased by +$1.53 million (+20.62%).
- EVOK TTM operating profit is now -1074.04% below its all-time high of -$502.40 thousand, reached on March 31, 2012.
Performance
EVOK TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
EVOK Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +4.6% | +31.9% | +20.6% |
| 3 y3 years | +43.0% | +27.9% | +22.0% |
| 5 y5 years | +7.3% | +27.9% | +22.0% |
EVOK Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +8.8% | -5.1% | +40.3% | at high | +27.6% |
| 5 y | 5-year | -3.9% | +43.0% | -5.1% | +81.5% | at high | +57.4% |
| alltime | all time | -271.1% | +43.5% | -532.1% | +81.5% | -1074.0% | +57.4% |
Evoke Pharma Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$1.29 M(+5.1%) | -$5.90 M(-5.1%) |
| Jun 2024 | - | -$1.22 M(-18.5%) | -$6.22 M(-8.3%) |
| Mar 2024 | - | -$1.50 M(-20.5%) | -$6.78 M(-8.8%) |
| Dec 2023 | -$7.43 M(-4.6%) | -$1.89 M(+17.7%) | -$7.43 M(+2.5%) |
| Sep 2023 | - | -$1.60 M(-10.1%) | -$7.25 M(-4.1%) |
| Jun 2023 | - | -$1.78 M(-17.2%) | -$7.56 M(-4.2%) |
| Mar 2023 | - | -$2.16 M(+26.0%) | -$7.89 M(+1.3%) |
| Dec 2022 | -$7.79 M(-4.5%) | -$1.71 M(-10.6%) | -$7.79 M(+2.1%) |
| Sep 2022 | - | -$1.91 M(-9.5%) | -$7.62 M(+0.9%) |
| Jun 2022 | - | -$2.11 M(+3.0%) | -$7.56 M(-0.7%) |
| Mar 2022 | - | -$2.05 M(+32.6%) | -$7.61 M(-6.6%) |
| Dec 2021 | -$8.15 M(-37.5%) | -$1.55 M(-16.1%) | -$8.15 M(-7.5%) |
| Sep 2021 | - | -$1.84 M(-14.9%) | -$8.81 M(-2.6%) |
| Jun 2021 | - | -$2.17 M(-16.3%) | -$9.05 M(-34.6%) |
| Mar 2021 | - | -$2.59 M(+17.3%) | -$13.84 M(+6.1%) |
| Dec 2020 | -$13.05 M(+82.4%) | -$2.21 M(+6.2%) | -$13.05 M(+6.4%) |
| Sep 2020 | - | -$2.08 M(-70.1%) | -$12.26 M(+3.7%) |
| Jun 2020 | - | -$6.96 M(+288.3%) | -$11.82 M(+69.4%) |
| Mar 2020 | - | -$1.79 M(+25.9%) | -$6.98 M(-2.5%) |
| Dec 2019 | -$7.15 M(-10.7%) | -$1.42 M(-13.0%) | -$7.15 M(-4.6%) |
| Sep 2019 | - | -$1.64 M(-22.9%) | -$7.50 M(+1.5%) |
| Jun 2019 | - | -$2.12 M(+7.8%) | -$7.38 M(-2.4%) |
| Mar 2019 | - | -$1.97 M(+11.4%) | -$7.57 M(-5.6%) |
| Dec 2018 | -$8.01 M | -$1.77 M(+16.1%) | -$8.01 M(-10.0%) |
| Sep 2018 | - | -$1.52 M(-34.0%) | -$8.91 M(-19.7%) |
| Jun 2018 | - | -$2.31 M(-4.6%) | -$11.08 M(-5.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | -$2.42 M(-9.1%) | -$11.67 M(+3.9%) |
| Dec 2017 | -$11.23 M(+6.5%) | -$2.66 M(-28.2%) | -$11.23 M(+3.1%) |
| Sep 2017 | - | -$3.70 M(+28.1%) | -$10.90 M(+16.4%) |
| Jun 2017 | - | -$2.89 M(+45.9%) | -$9.36 M(-0.1%) |
| Mar 2017 | - | -$1.98 M(-14.8%) | -$9.37 M(-11.1%) |
| Dec 2016 | -$10.54 M(-10.8%) | -$2.32 M(+7.1%) | -$10.54 M(-2.1%) |
| Sep 2016 | - | -$2.17 M(-25.1%) | -$10.77 M(-4.3%) |
| Jun 2016 | - | -$2.90 M(-8.1%) | -$11.26 M(-2.3%) |
| Mar 2016 | - | -$3.15 M(+23.6%) | -$11.53 M(-2.5%) |
| Dec 2015 | -$11.82 M(-10.1%) | -$2.55 M(-4.0%) | -$11.82 M(-3.0%) |
| Sep 2015 | - | -$2.66 M(-16.0%) | -$12.18 M(-8.7%) |
| Jun 2015 | - | -$3.16 M(-8.1%) | -$13.35 M(-2.4%) |
| Mar 2015 | - | -$3.45 M(+18.2%) | -$13.67 M(+4.0%) |
| Dec 2014 | -$13.15 M(+405.4%) | -$2.91 M(-23.7%) | -$13.15 M(+11.3%) |
| Sep 2014 | - | -$3.82 M(+9.4%) | -$11.82 M(+39.3%) |
| Jun 2014 | - | -$3.49 M(+19.5%) | -$8.48 M(+63.3%) |
| Mar 2014 | - | -$2.92 M(+84.9%) | -$5.19 M(+99.6%) |
| Dec 2013 | -$2.60 M(+29.9%) | -$1.58 M(+225.5%) | -$2.60 M(+54.6%) |
| Sep 2013 | - | -$485.60 K(+138.7%) | -$1.68 M(+0.5%) |
| Jun 2013 | - | -$203.40 K(-38.7%) | -$1.68 M(-8.6%) |
| Mar 2013 | - | -$332.00 K(-49.8%) | -$1.83 M(-8.5%) |
| Dec 2012 | -$2.00 M(-17.1%) | -$661.90 K(+38.6%) | -$2.00 M(+49.4%) |
| Sep 2012 | - | -$477.70 K(+32.6%) | -$1.34 M(+55.4%) |
| Jun 2012 | - | -$360.30 K(-28.3%) | -$862.70 K(+71.7%) |
| Mar 2012 | - | -$502.40 K | -$502.40 K |
| Dec 2011 | -$2.41 M | - | - |
FAQ
- What is Evoke Pharma annual operating income?
- What is the all time high annual operating profit for Evoke Pharma?
- What is Evoke Pharma annual operating profit year-on-year change?
- What is Evoke Pharma quarterly operating income?
- What is the all time high quarterly operating profit for Evoke Pharma?
- What is Evoke Pharma quarterly operating profit year-on-year change?
- What is Evoke Pharma TTM operating income?
- What is the all time high TTM operating profit for Evoke Pharma?
- What is Evoke Pharma TTM operating profit year-on-year change?
What is Evoke Pharma annual operating income?
The current annual operating profit of EVOK is -$7.43 M
What is the all time high annual operating profit for Evoke Pharma?
Evoke Pharma all-time high annual operating income is -$2.00 M
What is Evoke Pharma annual operating profit year-on-year change?
Over the past year, EVOK annual operating income has changed by +$355.20 K (+4.56%)
What is Evoke Pharma quarterly operating income?
The current quarterly operating profit of EVOK is -$1.29 M
What is the all time high quarterly operating profit for Evoke Pharma?
Evoke Pharma all-time high quarterly operating income is -$203.40 K
What is Evoke Pharma quarterly operating profit year-on-year change?
Over the past year, EVOK quarterly operating income has changed by +$602.20 K (+31.90%)
What is Evoke Pharma TTM operating income?
The current TTM operating profit of EVOK is -$5.90 M
What is the all time high TTM operating profit for Evoke Pharma?
Evoke Pharma all-time high TTM operating income is -$502.40 K
What is Evoke Pharma TTM operating profit year-on-year change?
Over the past year, EVOK TTM operating income has changed by +$1.53 M (+20.62%)